Myrto Moutafi

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Myrto Moutafi, Charles T. Robbins, Vesal Yaghoobi et al. · Laboratory Investigation · 2022 · 133 citations

Breast Oncology, Her2 Expression, Endocrine-related Cancer +9

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

Myrto Moutafi, Weiwei Tao, Richard S.P. Huang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text

A new tool for technical standardization of the Ki67 immunohistochemical assay

Thazin Nwe Aung, Balázs Ács, Jonathan Warrell et al. · Modern Pathology · 2021 · 48 citations · Full text

Immunocytochemical Technique, Engineering, New Tool +14

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Myrto Moutafi, Magdalena Molero, Sandra Martinez Morilla et al. · Journal for ImmunoTherapy of Cancer · 2022 · 38 citations · Full text

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Myrto Moutafi, Sandra Martínez-Morilla, Prajan Divakar et al. · Journal of Thoracic Oncology · 2022 · 37 citations · Full text

Cancer Immunosurveillance, Medicine, Biomarker Target +9